NEUROGENE INC.

Profile

Company Names

NEUROGENE INC.

Addresses

535 W. 24TH ST FL 5, NEW YORK, NY 10011

434 WEST 33RD STREET, NEW YORK, NY 10001

Phone Numbers

646-921-0610

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$106,499,981.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-12-15 
$68,999,980.00 
$114,999,965.00 
$45,999,985.00 
Equity 
1
2019-02-08 
$37,500,001.00 
$37,500,001.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
BAFFI 
DIRECTOR
NEUROGENE INC.
STEPHEN 
 
BIGGAR 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  SYNAGEVA BIOPHARMA CORP   |  BBDX, INC.   |  NEUROGENE INC.
CHRISTINE 
MIKAIL 
CVIJIC 
EXECUTIVE OFFICER
NEUMENTUM, INC.   |  NATIVE CARDIO, INC.   |  NEUROGENE INC.
CORY 
 
FREEDLAND 
DIRECTOR
BIOCLIN THERAPEUTICS, INC.   |  NEUROGENE INC.   |  PALVELLA THERAPEUTICS, INC.   |  TENTARIX BIOTHERAPEUTICS, LP   |  ORSOBIO, INC.
RACHEL 
 
MCMINN 
EXECUTIVE OFFICER, DIRECTOR
NEUROGENE INC.
SRDJAN 
 
STANKOVIC 
DIRECTOR
NEUROGENE INC.
CAROLINE 
 
STOUT 
DIRECTOR
NEOGENE THERAPEUTICS, INC.   |  NEUROGENE INC.   |  AFFINIA THERAPEUTICS INC.   |  NOTCH THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-12-29
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-15 
2019-02-25
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#